Pre-emptive Local Anesthesia and Sevoflurane Consumption in Pediatric Dental Anesthesia

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age4-12
SponsorTC Erciyes University

About this trial

This study will evaluate whether pre-emptive local anesthesia reduces sevoflurane consumption during pediatric day-case dental treatment performed under general anesthesia.

Children aged 4 to 12 years scheduled for elective dental treatment under general anesthesia will be included. Participants will be assigned to either receive pre-emptive local anesthesia before the dental procedure or receive no pre-emptive local anesthesia. General anesthesia will be standardized using sevoflurane, low fresh gas flow, endotracheal intubation, and bispectral index monitoring.

The main outcome will be sevoflurane consumption expressed as mL/kg/hour. Secondary outcomes will include anesthetic agent uptake, time from sevoflurane discontinuation to extubation, and estimated carbon dioxide-equivalent emissions.

The aim is to determine whether pre-emptive local anesthesia can reduce volatile anesthetic requirement and improve early recovery while maintaining adequate anesthetic depth in children undergoing dental general anesthesia.

Eligibility criteria

Qualifiers

Children aged 4 to 12 years

Scheduled for elective day-case dental treatment under general anesthesia

ASA physical status I or II

Planned sevoflurane-based general anesthesia

Disqualifiers

Age younger than 4 years or older than 12 years

ASA physical status III or higher

Emergency dental procedures

Known allergy or contraindication to sevoflurane

Trial design

Treatments tested in this trial

  • Pre-emptive Local Anesthesia
  • Articaine With Epinephrine
  • Sevoflurane

Treatment groups

80 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators